BioCentury
ARTICLE | Clinical News

Neumega interleukin-11 data

April 15, 2013 7:00 AM UTC

Genetics Institute published in the Journal of Clinical Oncology the results of a placebo-controlled trial of IL-11 in women with high-risk breast cancer and low platelet counts due to chemotherapy. A total of 77 women received two cycles of chemotherapy plus Amgen Inc.'s Neupogen G-CSF, followed by placebo or 50 µg/kg/day of IL-11 subcutaneously for 10-17 days. ...